These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31251537)

  • 1. Protection Efficacy of a Recombinant Herpesvirus of Turkey Vaccine Against Infectious Laryngotracheitis Virus Administered
    Maekawa D; Beltrán G; Riblet SM; García M
    Avian Dis; 2019 Jun; 63(2):351-358. PubMed ID: 31251537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of vaccination against infectious laryngotracheitis (ILT) with recombinant herpesvirus of turkey (rHVT-LT) and chicken embryo origin (CEO) vaccines applied alone or in combination.
    Maekawa D; Riblet SM; Newman L; Koopman R; Barbosa T; García M
    Avian Pathol; 2019 Dec; 48(6):573-581. PubMed ID: 31304770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection Efficacy of Recombinant HVT-ND-LT and the Live Attenuated Tissue Culture Origin Vaccines Against Infectious Laryngotracheitis Virus When Administered Individually or in Combination.
    Becerra R; Maekawa D; García M
    Avian Dis; 2023 Jun; 67(2):145-152. PubMed ID: 37556293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication of recombinant herpesvirus of turkey expressing genes of infectious laryngotracheitis virus in specific pathogen free and broiler chickens following in ovo and subcutaneous vaccination.
    Gimeno IM; Cortes AL; Guy JS; Turpin E; Williams C
    Avian Pathol; 2011 Aug; 40(4):395-403. PubMed ID: 21812719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
    Palomino-Tapia VA; Zavala G; Cheng S; García M
    Avian Pathol; 2019 Jun; 48(3):209-220. PubMed ID: 30640536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against infectious laryngotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines.
    Johnson DI; Vagnozzi A; Dorea F; Riblet SM; Mundt A; Zavala G; García M
    Avian Dis; 2010 Dec; 54(4):1251-9. PubMed ID: 21313847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Ovo Vaccination with Recombinant Herpes Virus of the Turkey-Laryngotracheitis Vaccine Adjuvanted with CpG-Oligonucleotide Provides Protection against a Viral Challenge in Broiler Chickens.
    Gaghan C; Browning M; Fares AM; Abdul-Careem MF; Gimeno IM; Kulkarni RR
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens.
    Vagnozzi A; Zavala G; Riblet SM; Mundt A; García M
    Avian Pathol; 2012; 41(1):21-31. PubMed ID: 22845318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cell Line Adapted Infectious Laryngotracheitis Virus Strain (BΔORFC) for
    Maekawa D; Riblet SM; Whang P; Alvarado I; García M
    Avian Dis; 2021 Sep; 65(3):500-507. PubMed ID: 34699149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future vaccines and vaccination strategies against infectious laryngotracheitis (ILT) respiratory disease of poultry.
    García M
    Vet Microbiol; 2017 Jul; 206():157-162. PubMed ID: 28057380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W; Spatz S; Zhang Z; Wen G; Garcia M; Zsak L; Yu Q
    J Virol; 2014 Aug; 88(15):8397-406. PubMed ID: 24829337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and vaccine efficacy of a glycoprotein G deficient strain of infectious laryngotracheitis virus delivered in ovo.
    Legione AR; Coppo MJ; Lee SW; Noormohammadi AH; Hartley CA; Browning GF; Gilkerson JR; O'Rourke D; Devlin JM
    Vaccine; 2012 Nov; 30(50):7193-8. PubMed ID: 23084851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Protection Efficacy of a Serotype 1 Marek's Disease Virus-Vectored Bivalent Vaccine Against Infectious Laryngotracheitis and Marek's Disease.
    Gimeno IM; Cortes AL; Faiz NM; Hernandez-Ortiz BA; Guy JS; Hunt HD; Silva RF
    Avian Dis; 2015 Jun; 59(2):255-62. PubMed ID: 26473676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo safety and efficacy of a glycoprotein G-deficient candidate vaccine strain of infectious laryngotracheitis virus delivered via eye drop.
    Coppo MJ; Noormohammadi AH; Hartley CA; Gilkerson JR; Browning GF; Devlin JM
    Avian Pathol; 2011 Aug; 40(4):411-7. PubMed ID: 21812721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the transcriptional status of host cytokines and viral genes in the trachea of vaccinated and non-vaccinated chickens after challenge with the infectious laryngotracheitis virus.
    Vagnozzi A; Riblet S; Zavala G; Ecco R; Afonso CL; García M
    Avian Pathol; 2016; 45(1):106-13. PubMed ID: 26926298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commercial Vaccines and Vaccination Strategies Against Infectious Laryngotracheitis: What We Have Learned and Knowledge Gaps That Remain.
    García M; Zavala G
    Avian Dis; 2019 Jun; 63(2):325-334. PubMed ID: 31251534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Nucleotide Polymorphism Genotyping Analysis Shows That Vaccination Can Limit the Number and Diversity of Recombinant Progeny of Infectious Laryngotracheitis Viruses from the United States.
    Loncoman CA; Hartley CA; Coppo MJC; Browning GF; Beltrán G; Riblet S; Freitas CO; García M; Devlin JM
    Appl Environ Microbiol; 2018 Dec; 84(23):. PubMed ID: 30242009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of a turkey herpesvirus vector laryngotracheitis vaccine for chickens.
    Esaki M; Noland L; Eddins T; Godoy A; Saeki S; Saitoh S; Yasuda A; Dorsey KM
    Avian Dis; 2013 Jun; 57(2):192-8. PubMed ID: 24689173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenic and Transmission Potential of Wildtype and Chicken Embryo Origin (CEO) Vaccine Revertant Infectious Laryngotracheitis Virus.
    Perez-Contreras A; Barboza-Solis C; Najimudeen SM; Checkley S; Meer FV; Joseph T; King R; Ravi M; Peters D; Fonseca K; Gagnon CA; Ojkic D; Abdul-Careem MF
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33805117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In ovo vaccination of commercial broilers with a glycoprotein J gene-deleted strain of infectious laryngotracheitis virus.
    Mashchenko A; Riblet SM; Zavala G; García M
    Avian Dis; 2013 Jun; 57(2 Suppl):523-31. PubMed ID: 23901771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.